Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)
India
· Delayed Price · Currency is INR 17.64
+0.20 (1.15%)
At close: Apr 28, 2026
BOM:524663 Revenue
Bharat Immunologicals & Biologicals Corporation had revenue of 76.50M INR in the twelve months ending September 30, 2023, down -89.99% year-over-year. In the fiscal year ending March 31, 2023, Bharat Immunologicals & Biologicals Corporation had annual revenue of 446.09M, down -43.09%.
Revenue (ttm)
76.50M
Revenue Growth
-89.99%
P/S Ratio
9.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
761.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 446.09M | -337.79M | -43.09% |
| Mar 31, 2022 | 783.88M | -69.46M | -8.14% |
| Mar 31, 2021 | 853.34M | 184.97M | 27.68% |
| Mar 31, 2020 | 668.37M | -168.09M | -20.10% |
| Mar 31, 2019 | 836.46M | 488.47M | 140.37% |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
| Mar 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunsky Logistics | 238.95M |
| Shantidoot Infra Services | 426.62M |
| Maestros Electronics & Telecommunications Systems | 353.65M |
| Baba Arts | 126.87M |
| Garg Furnace | 2.90B |
| SecureKloud Technologies | 1.08B |
| Sarda Proteins | 155.09M |
| TPI India | 322.39M |